MedCity News April 29, 2024
Stephanie Baum

Eligible small businesses may receive millions of non-dilutive dollars from NIH’s Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs. Funding comes in tranches, from $300,000 – $4 million, based upon the stage of development and likelihood of the end product “moving the needle” in healthcare.

With over $1.3B dollars each year to fund U.S. startups, the National Institutes of Health (NIH) Small Business portfolio consists of life science companies dedicated to developing a full range of advanced technologies and products to improve the human condition.

Eligible small businesses may receive multiple millions of non-dilutive dollars from NIH’s Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs. Funding comes in tranches, from $300,000 –...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Pharma / Biotech, Trends
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
AZ plots $1.5B antibody-drug conjugate plant in Asia
STAT+: AI & drug discovery: A biotech CEO, a scientist, and a venture capitalist separate hype from reality
Pharma Pulse 5/20/24: The Future of RBQM Adoption, AI Innovating Pregnancy Care and Cancer Screening & more
Hims & Hers adds GLP-1 injections to weight loss program

Share This Article